Education
About Us
Working with TipRanks
Follow Us
Isofol Medical AB (DE:5IU)
FRANKFURT:5IU
Total Valuation
Isofol Medical AB has a market cap or net worth of €18.27M. The enterprise value is €86.17M.
Market Cap€18.27M
Enterprise Value€86.17M
Share Statistics
Isofol Medical AB has 281,107,240 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding281,107,240
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Isofol Medical AB’s return on equity (ROE) is -0.56 and return on invested capital (ROIC) is -60.07%.
Return on Equity (ROE)-0.56
Return on Assets (ROA)-0.44
Return on Invested Capital (ROIC)-60.07%
Return on Capital Employed (ROCE)-0.60
Revenue Per Employee0.00
Profits Per Employee-8.70M
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Isofol Medical AB is ―. Isofol Medical AB’s PEG ratio is -0.47.
PE Ratio―
PS Ratio0.00
PB Ratio4.59
Price to Fair Value4.59
Price to FCF-8.52
Price to Operating Cash Flow-2.36
PEG Ratio-0.47
Income Statement
In the last 12 months, Isofol Medical AB had revenue of 0.00 and earned -43.49M in profits. Earnings per share was -0.27.
Revenue0.00
Gross Profit-38.73M
Operating Income-47.21M
Pretax Income-43.49M
Net Income-43.49M
EBITDA-47.21M
Earnings Per Share (EPS)-0.27
Cash Flow
In the last 12 months, operating cash flow was -48.84M and capital expenditures 0.00, giving a free cash flow of -48.84M billion.
Operating Cash Flow-48.84M
Free Cash Flow-48.84M
Free Cash Flow per Share-0.17
Dividends & Yields
Isofol Medical AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.24
52-Week Price Change-70.59%
50-Day Moving Average0.05
200-Day Moving Average0.08
Relative Strength Index (RSI)47.50
Average Volume (3m)0.00
Important Dates
Isofol Medical AB upcoming earnings date is Feb 18, 2026, TBA (Confirmed).
Last Earnings DateNov 12, 2025
Next Earnings DateFeb 18, 2026
Ex-Dividend Date―
Financial Position
Isofol Medical AB as a current ratio of 4.96, with Debt / Equity ratio of 0.00%
Current Ratio4.96
Quick Ratio4.96
Debt to Market Cap0.00
Net Debt to EBITDA2.04
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Isofol Medical AB has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Isofol Medical AB EV to EBITDA ratio is -5.54, with an EV/FCF ratio of -6.23.
EV to Sales0.00
EV to EBITDA-5.54
EV to Free Cash Flow-6.23
EV to Operating Cash Flow-6.23
Balance Sheet
Isofol Medical AB has €138.79M in cash and marketable securities with €0.00 in debt, giving a net cash position of €138.79M billion.
Cash & Marketable Securities€138.79M
Total Debt€0.00
Net Cash€138.79M
Net Cash Per Share€0.49
Tangible Book Value Per Share€0.48
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Isofol Medical AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―